{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-031343","form_type":"8-K","ticker":"PETV","cik":"0001512922","company_name":"PetVivo Holdings, Inc.","filed_at":"2022-11-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.927199+00:00","generated_at":"2026-06-21T22:49:56.786406+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"PetVivo Q2 FY2023 revenue $223K; net loss $2.1M as Spryng shipments begin to distributor","bullets":["Revenue of $223,280, up from $4,977 YoY, driven by Spryng sales to clinics and distributor MWI.","Net loss of $2.1M ($0.21/share) vs $1.1M ($0.13/share), due to higher operating expenses for commercialization.","Spryng shipments to MWI Animal Health began in Q2; $118,264 revenue from distributor.","Cash and equivalents $2.3M; working capital $2.1M; inventory increased to $304,967.","Accounts opened in 47 states; lead product Spryng for osteoarthritis in dogs/horses."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-031343","json":"https://secwatch.observer/filing/0001493152-22-031343.json","markdown":"https://secwatch.observer/filing/0001493152-22-031343.md","text":"https://secwatch.observer/filing/0001493152-22-031343.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1512922/000149315222031343/0001493152-22-031343-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1512922/000149315222031343/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T22:49:56.786406+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"00dde93db4d85ae78482dc8569462d5b4bae1e80","claim":"PetVivo Holdings, Inc. reported the second quarter ended September 30, 2022 results: revenue $223,280, net income $2,111,589, EPS ($0.21) per share.","evidence_excerpt":"quarter of fiscal year 2023 and recent weeks include the following (all comparisons are with the second quarter of fiscal year 2022, unless otherwise indicated): ● Revenues of $223,280 for the three months ended September 30, 2022, compared to revenues of $4,977 in the three months ended September 30, 2021; ● Net revenue of $118,264 was from shipments of","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1512922/000149315222031343/0001493152-22-031343-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the second quarter ended September 30, 2022"},{"label":"Revenue","value":"$223,280"},{"label":"Net income","value":"$2,111,589"},{"label":"EPS","value":"($0.21) per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}